Clinical characteristics, cause analysis and infectivity of COVID-19 nucleic acid repositive patients : A literature review
© 2020 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC..
Coronavirus disease 2019 (COVID-19) poses a serious threat to human health and lives. The virus is still spreading throughout the world, and the cumulative number of confirmed cases is increasing. After patients with COVID-19 are treated and discharged, some have repeated clinical symptoms and become positive for nucleic acid tests a second time. Through analysis and review of the existing literature, the proportion of repositive patients in the discharged patient population and their clinical characteristics were systematically described for the first time. Furthermore, an in-depth analysis of the causes of repositive nucleic acid tests and the potential transmission of the disease provides the basis for the management and protection of discharged patients with COVID-19.
| Errataetall: |
ErratumIn: J Med Virol. 2022 Mar;94(3):1247. - PMID 34907540 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:93 |
|---|---|
| Enthalten in: |
Journal of medical virology - 93(2021), 3 vom: 25. März, Seite 1288-1295 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Li, Youjiang [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 10.03.2021 Date Revised 30.03.2024 published: Print-Electronic ErratumIn: J Med Virol. 2022 Mar;94(3):1247. - PMID 34907540 Citation Status MEDLINE |
|---|
| doi: |
10.1002/jmv.26491 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM314631577 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM314631577 | ||
| 003 | DE-627 | ||
| 005 | 20240330232820.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/jmv.26491 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1356.xml |
| 035 | |a (DE-627)NLM314631577 | ||
| 035 | |a (NLM)32890414 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Li, Youjiang |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinical characteristics, cause analysis and infectivity of COVID-19 nucleic acid repositive patients |b A literature review |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.03.2021 | ||
| 500 | |a Date Revised 30.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ErratumIn: J Med Virol. 2022 Mar;94(3):1247. - PMID 34907540 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2020 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC. | ||
| 520 | |a Coronavirus disease 2019 (COVID-19) poses a serious threat to human health and lives. The virus is still spreading throughout the world, and the cumulative number of confirmed cases is increasing. After patients with COVID-19 are treated and discharged, some have repeated clinical symptoms and become positive for nucleic acid tests a second time. Through analysis and review of the existing literature, the proportion of repositive patients in the discharged patient population and their clinical characteristics were systematically described for the first time. Furthermore, an in-depth analysis of the causes of repositive nucleic acid tests and the potential transmission of the disease provides the basis for the management and protection of discharged patients with COVID-19 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a RT-PCR test | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a recovered patients | |
| 650 | 7 | |a RNA, Viral |2 NLM | |
| 700 | 1 | |a Ji, Danping |e verfasserin |4 aut | |
| 700 | 1 | |a Cai, Wangyu |e verfasserin |4 aut | |
| 700 | 1 | |a Hu, Yingying |e verfasserin |4 aut | |
| 700 | 1 | |a Bai, Yongying |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Jianguo |e verfasserin |4 aut | |
| 700 | 1 | |a Xu, Jian |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of medical virology |d 1980 |g 93(2021), 3 vom: 25. März, Seite 1288-1295 |w (DE-627)NLM000285676 |x 1096-9071 |7 nnns |
| 773 | 1 | 8 | |g volume:93 |g year:2021 |g number:3 |g day:25 |g month:03 |g pages:1288-1295 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/jmv.26491 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 93 |j 2021 |e 3 |b 25 |c 03 |h 1288-1295 | ||